Yoichi Ishitsuka

HPGCD Outperforms HPBCD as a Potential Treatment for Niemann-Pick Disease Type C During Disease Modeling with iPS Cells

Minami Soga, Yoichi Ishitsuka, Makoto Hamasaki et al. · Stem Cells · 2014 · 100 citations

Hpgcd Outperforms Hpbcd, Pathology, Translational Medicine +22

Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann–Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease

Y. Tanaka, Yusei Yamada, Yoichi Ishitsuka et al. · Biological and Pharmaceutical Bulletin · 2015 · 85 citations · Full text

Subcutaneous Injection, Pharmacotherapy, Pharmacokinetic Analysis +17

The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice

Y. Tanaka, Yoichi Ishitsuka, Marina Hayasaka et al. · Pharmacological Research · 2015 · 51 citations

Inflammation, Fibrosis, Antifibrotic Therapy +11

Effects of intracerebroventricular administration of 2-hydroxypropyl-β-cyclodextrin in a patient with Niemann–Pick Type C disease

Muneaki Matsuo, Koki Shraishi, Koki Wada et al. · Molecular Genetics and Metabolism Reports · 2014 · 50 citations · Full text

Anti-inflammatory Effects of Novel Polysaccharide Sacran Extracted from Cyanobacterium <i>Aphanothece sacrum</i> in Various Inflammatory Animal Models

Keiichi Motoyama, Yuki Tanida, Kyona Hata et al. · Biological and Pharmaceutical Bulletin · 2016 · 39 citations · Full text

Aphanothece Sacrum, Immunology, Anti-inflammatory Effects +18